Familial hypercholesterolemia (FH) is the most frequent genetic lipoprotein disorder associated with premature coronary artery disease.  The goal of this initiative is to create a registry of subjects with FH across Canada. The registry will help clinicians and researchers to determine the burden

CFDI STUDY with ENZYME REPLACEMENT THERAPY (ERT)

This is an observational study of patients with Primary Mitochondrial Disease with either signs or symptoms suggestive of myopathy.